Our Flagship Product: VECanDx ELISA Test

For the detection of bladder cancer non-invasively in hematuria and recurrent bladder cancer patients.

Enzyme-linked immunosorbent assay (ELISA) is routinely used in hospitals for detection and quantification of biomarkers specific to various diseases using patient samples. Our ELISA IVD test will employ standard ELISA procedures that are well established in numerous hospitals for sensitive detection of the five bladder cancer biomarkers patented by BioCheetah.

We utilise immunoassays to detect five specific protein biomarkers that are present exclusively in bladder cancer. Thus, the multiplex biomarker panel offers unprecedented accuracy for the diagnosis of bladder cancer and provides the prospect for a non-invasive way to detect bladder cancer in patients.

Bio Cheetah
Bio Cheetah
For hematuria & high-risk individuals
Bio Cheetah
Non-invasive & rapid bladder cancer test
Bio Cheetah
Offers affordable and accurate detection of bladder cancer
Bio Cheetah
High sensitivity and specificity to early and late stage of bladder cancer
Bio Cheetah
Allow better patient triage & effective clinical resources
Bio Cheetah

Our Pipeline Product

Our Point-of-Care Testing (POCT) kit is currently under development that caters to General Practitioners (GPs) and polyclinics for rapid qualitative analysis of the bladder cancer biomarkers. By utilizing the lateral flow immunoassay which is a proven and well-established technology, it enables rapid testing for patients from bench to bedside.

Learn More